Martin Metz Selected Research

Bacterial Infections (Bacterial Infection)

1/2011	Effects of antihistamines on innate immune responses to severe bacterial infection in mice.
12/2009	Innate immunity and allergy in the skin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Metz Research Topics

Disease

32	Chronic Urticaria 01/2022 - 07/2009
18	Pruritus (Itching) 02/2022 - 01/2010
18	Urticaria (Hives) 12/2021 - 01/2010
16	Inflammation (Inflammations) 01/2020 - 09/2006
11	Hypersensitivity (Allergy) 01/2021 - 08/2003
9	Anaphylaxis (Anaphylactic Shock) 03/2020 - 12/2006
7	Prurigo 01/2022 - 03/2013
7	Cold Urticaria 12/2021 - 01/2010
7	Contact Dermatitis (Eczema, Contact) 01/2019 - 08/2003
6	Angioedema 01/2021 - 12/2015
5	Atopic Dermatitis (Atopic Eczema) 02/2022 - 10/2012
4	Asthma (Bronchial Asthma) 01/2020 - 12/2009
4	Familial dermographism 01/2018 - 01/2011
3	Solar Urticaria 01/2018 - 01/2011
3	Chronic Inducible Urticaria 01/2018 - 01/2014
3	Infections 04/2012 - 06/2007
3	Sepsis (Septicemia) 01/2011 - 08/2007
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 07/2021
2	Neoplasms (Cancer) 12/2021 - 03/2014
2	Skin Diseases (Skin Disease) 01/2021 - 12/2016
2	Hereditary Angioedemas 01/2020 - 04/2010
2	Wounds and Injuries (Trauma) 10/2019 - 03/2013
2	Necrosis 01/2017 - 01/2012
2	Bacterial Infections (Bacterial Infection) 01/2011 - 12/2009
2	Peritonitis 01/2011 - 08/2007
2	Immediate Hypersensitivity 12/2009 - 12/2006
1	Pain (Aches) 01/2021
1	Drug Hypersensitivity (Drug Allergy) 01/2021
1	COVID-19 01/2021
1	Wells syndrome 07/2020
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 11/2019
1	Cicatrix (Scar) 10/2019
1	Parasitic Diseases (Parasitic Disease) 10/2019

Drug/Important Bio-Agent (IBA)

22	Omalizumab (Xolair)FDA Link 01/2022 - 09/2010
15	Immunoglobulin E (IgE)IBA 01/2022 - 12/2006
9	Histamine (Histamine Dihydrochloride)FDA Link 02/2022 - 10/2009
8	Histamine Antagonists (Antihistamines)IBA 01/2022 - 01/2011
8	AllergensIBA 12/2021 - 08/2003
6	CytokinesIBA 02/2022 - 06/2007
5	Pharmaceutical PreparationsIBA 01/2021 - 08/2012
5	Substance PIBA 01/2021 - 04/2011
5	AntigensIBA 03/2020 - 12/2006
5	AntipruriticsIBA 04/2019 - 09/2013
4	Cholinergic Agents (Cholinergics)IBA 01/2020 - 03/2014
4	anti-IgE antibodiesIBA 01/2019 - 01/2014
4	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 08/2007
3	ligelizumabIBA 01/2022 - 10/2019
3	Immunoglobulin G (IgG)IBA 01/2022 - 07/2021
3	NeuropeptidesIBA 01/2022 - 04/2008
3	AutoantibodiesIBA 11/2021 - 04/2011
3	AntibodiesIBA 07/2021 - 11/2013
3	VenomsIBA 03/2020 - 11/2013
3	BradykininIBA 01/2020 - 04/2010
3	Tryptases (Tryptase)IBA 10/2019 - 10/2009
3	rupatadineIBA 12/2015 - 01/2010
3	Chymases (Chymase)IBA 02/2014 - 08/2007
3	Interleukin-6 (Interleukin 6)IBA 02/2014 - 01/2012
3	Interleukin-10 (Interleukin 10)IBA 01/2012 - 08/2003
2	Interleukin-13IBA 02/2022 - 02/2014
2	Interleukin-4 (Interleukin 4)IBA 02/2022 - 01/2012
2	Iodide Peroxidase (Deiodinase)IBA 01/2022 - 04/2011
2	dupilumabIBA 09/2021 - 01/2019
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 01/2021
2	mepolizumabIBA 07/2020 - 04/2018
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2019 - 05/2009
2	Aprepitant (Emend)FDA Link 04/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2014
2	canakinumab FDA Link 04/2017 - 09/2013
2	mast cell protease 4IBA 02/2014 - 03/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2013 - 03/2013
2	Thymic Stromal LymphopoietinIBA 04/2012 - 12/2009
2	Peptides (Polypeptides)IBA 05/2009 - 04/2008
2	Bacterial ToxinsIBA 05/2009 - 02/2009
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	cortistatinIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	GSK2646264IBA 12/2021
1	Syk KinaseIBA 12/2021
1	enfortumab vedotinIBA 12/2021
1	fenebrutinibIBA 11/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2021
1	baricitinibIBA 09/2021
1	Antinuclear AntibodiesIBA 07/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	LigandsIBA 01/2021
1	Eosinophil Major Basic ProteinIBA 01/2021
1	Biological ProductsIBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	reslizumabIBA 11/2019
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 10/2019
1	CathelicidinsIBA 10/2019
1	Codeine (Codeine Phosphate)FDA LinkGeneric 07/2019

Therapy/Procedure

23	Therapeutics 01/2022 - 09/2010
3	Injections 01/2014 - 09/2006
3	Punctures 01/2011 - 08/2007
3	Ligation 01/2011 - 08/2007
1	Biological Therapy 01/2021
1	Self Administration (Administration, Self) 01/2021